Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Raw Materials (2019 - 2022)

Marimed (MRMD) has disclosed Raw Materials for 4 consecutive years, with $2.4 million as the latest value for Q1 2022.

  • Quarterly Raw Materials fell 35.03% to $2.4 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Mar 2022, down 35.03% year-over-year, with the annual reading at $1.0 million for FY2021, 475.6% up from the prior year.
  • Raw Materials for Q1 2022 was $2.4 million at Marimed, up from $1.0 million in the prior quarter.
  • The five-year high for Raw Materials was $3.7 million in Q1 2021, with the low at $176338.0 in Q4 2020.
  • Average Raw Materials over 4 years is $1.6 million, with a median of $1.0 million recorded in 2021.
  • The sharpest move saw Raw Materials skyrocketed 475.6% in 2021, then crashed 35.03% in 2022.
  • Over 4 years, Raw Materials stood at $225620.0 in 2019, then dropped by 21.84% to $176338.0 in 2020, then surged by 475.6% to $1.0 million in 2021, then skyrocketed by 137.73% to $2.4 million in 2022.
  • According to Business Quant data, Raw Materials over the past three periods came in at $2.4 million, $1.0 million, and $256331.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.